Skip to main content
NCBI home page
Journal of Clinical Pathology. Supplement (Royal College of Pathologists) logoLink to Journal of Clinical Pathology. Supplement (Royal College of Pathologists)
. 1974;7:65–71. doi: 10.1136/jcp.s3-7.1.65

Hormones and neoplasia

A P M Forrest 1
PMCID: PMC1347229  PMID: 4364584

Full text

PDF
65

Images in this article

67Image
on p.67

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BAULD W. S., GIVNER M. L., MILNE I. G. Abnormality of estrogen metabolism in human subjects with myocardial infarction. Can J Biochem Physiol. 1957 Dec;35(12):1277–1288. [PubMed] [Google Scholar]
  2. Boyns A. R., Buchan R., Cole E. N., Forrest A. P., Griffiths K. Basal prolactin blood levels in three strains of rat with differing incidence of 7,12-dimethylbenz(a)anthracene induced mammary tumours. Eur J Cancer. 1973 Mar;9(3):169–171. doi: 10.1016/s0014-2964(73)80015-5. [DOI] [PubMed] [Google Scholar]
  3. Boyns A. R., Cole E. N., Griffiths K., Roberts M. M., Buchan R., Wilson R. G., Forrest A. P. Plasma prolactin in breast cancer. Eur J Cancer. 1973 Feb;9(2):99–102. doi: 10.1016/0014-2964(73)90078-9. [DOI] [PubMed] [Google Scholar]
  4. Butler T. P., Pearson O. H. Regression of prolactin-dependent rat mammary carcinoma in response to antihormone treatment. Cancer Res. 1971 Jun;31(6):817–820. [PubMed] [Google Scholar]
  5. Cameron E. H., Griffiths K., Gleave E., Stewart H. J., Forrest A. P., Campbell H. Benign and malignant breast disease in South Wales: a study of urinary steroids. Br Med J. 1970 Dec 26;4(5738):768–771. doi: 10.1136/bmj.4.5738.768. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. DAO T. L., GREINER M. J. Mammary carcinogenesis by 3-methylcholanthrene. III. Induction of mammary carcinoma and milk secretion in male rats bearing ovarian grafts. J Natl Cancer Inst. 1961 Aug;27:333–349. [PubMed] [Google Scholar]
  7. Dao T. L., Libby P. R. Conjugation of steroid hormones by normal and neoplastic tissues. J Clin Endocrinol Metab. 1968 Oct;28(10):1431–1439. doi: 10.1210/jcem-28-10-1431. [DOI] [PubMed] [Google Scholar]
  8. HADFIELD G. J., HOLT J. A. The physiological castration syndrome in breast cancer. Br Med J. 1956 Oct 27;2(4999):972–973. doi: 10.1136/bmj.2.4999.972. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. HUGGINS C., BERGENSTAL D. M. Inhibition of human mammary and prostatic cancers by adrenalectomy. Cancer Res. 1952 Feb;12(2):134–141. [PubMed] [Google Scholar]
  10. HUGGINS C., BRIZIARELLI G., SUTTON H., Jr Rapid induction of mammary carcinoma in the rat and the influence of hormones on the tumors. J Exp Med. 1959 Jan 1;109(1):25–42. doi: 10.1084/jem.109.1.25. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. HUGGINS C., DAO T. L. Y. Adrenalectomy and oophorectomy in treatment of advanced carcinoma of the breast. J Am Med Assoc. 1953 Apr 18;151(16):1388–1394. [PubMed] [Google Scholar]
  12. Hellman L., Fishman J., Zumoff B., Cassouto J., Gallagher T. F. Studies of estradiol transformation in women with breast cancer. J Clin Endocrinol Metab. 1967 Aug;27(8):1087–1089. doi: 10.1210/jcem-27-8-1087. [DOI] [PubMed] [Google Scholar]
  13. JULL J. W. The effects of oestrogens and progesterone on the chemical induction of mammary cancer in mice of the IF strain. J Pathol Bacteriol. 1954 Oct;68(2):547–559. doi: 10.1002/path.1700680227. [DOI] [PubMed] [Google Scholar]
  14. Jenkins J. S., Ash S. Metabolism of testosterone by human breast tumours. Lancet. 1972 Sep 9;2(7776):513–514. doi: 10.1016/s0140-6736(72)91907-1. [DOI] [PubMed] [Google Scholar]
  15. Jones D., Cameron E. H., Griffiths K., Gleave E. N., Forrest A. P. Steroid metabolism by human breast tumours. Biochem J. 1970 Mar;116(5):919–921. doi: 10.1042/bj1160919. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. KENNEDY B. J. Extirpative endocrine therapy for advanced cancer of the breast. Am J Med. 1956 Nov;21(5):721–727. doi: 10.1016/0002-9343(56)90088-2. [DOI] [PubMed] [Google Scholar]
  17. LUFT R., OLIVECRONA H., SJOGREN B. Hypofysektomi på människa. Nord Med. 1952 Mar 14;47(11):351–354. [PubMed] [Google Scholar]
  18. LYONS W. R. Hormonal synergism in mammary growth. Proc R Soc Lond B Biol Sci. 1958 Dec 17;149(936):303–325. doi: 10.1098/rspb.1958.0071. [DOI] [PubMed] [Google Scholar]
  19. Lathrop A. E., Loeb L. Further investigations on the origin of tumors in mice. III. On the part played by internal secretion in the spontaneous development of tumors. J Cancer Res. 1916 Jan;1(1):1–19. [PubMed] [Google Scholar]
  20. Lowe C. R., MacMahon B. Breast cancer and reproductive history of women in South Wales. Lancet. 1970 Jan 24;1(7639):153–156. doi: 10.1016/s0140-6736(70)90401-0. [DOI] [PubMed] [Google Scholar]
  21. MARCHANT J. Influence of the strain of ovarian grafts on the induction of breast and ovarian tumors in F1 C57B1--1F hybrid mice by 9:10-dimethyl-1:2-benzanthracene. Br J Cancer. 1959 Jun;13:306–312. doi: 10.1038/bjc.1959.37. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. MARMORSTON J., CROWLEY L. G., MYERS S. M., STERN E., HOPKINS C. E. II. URINARY EXCRETION OF ESTRONE, ESTRADIOL, AND ESTRIOL BY PATIENTS WITH BREAST CANCER AND BENIGN BREAST DISEASE. Am J Obstet Gynecol. 1965 Jun 15;92:460–467. doi: 10.1016/s0002-9378(16)34835-9. [DOI] [PubMed] [Google Scholar]
  23. MCCALISTER A., WELBOURN R. B., EDELSTYN G. J., LYONS A. R., TAYLOR A. R., GLEADHILL C. A., GORDON D. S., COLE J. O. Factors influencing response to hypophysectomy for advanced cancer of breast. Br Med J. 1961 Mar 4;1(5226):613–617. doi: 10.1136/bmj.1.5226.613. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. MUSTACCHI P., SHIMKIN M. B. Occurrence of cancer in acromegaly and in hypopituitarism. Cancer. 1957 Jan-Feb;10(1):100–104. doi: 10.1002/1097-0142(195701/02)10:1<100::aid-cncr2820100113>3.0.co;2-v. [DOI] [PubMed] [Google Scholar]
  25. MacMahon B., Cole P., Brown J. B., Aoki K., Lin T. M., Morgan R. W., Woo N. Oestrogen profiles of Asian and North American women. Lancet. 1971 Oct 23;2(7730):900–902. doi: 10.1016/s0140-6736(71)92504-9. [DOI] [PubMed] [Google Scholar]
  26. MacMahon B., Lin T. M., Lowe C. R., Mirra A. P., Ravnihar B., Salber E. J., Trichopoulos D., Valaoras V. G., Yuasa S. Lactation and cancer of the breast. A summary of an international study. Bull World Health Organ. 1970;42(2):185–194. [PMC free article] [PubMed] [Google Scholar]
  27. McGuire W. L., Julian J. A. Comparison of macromolecular binding of estradiol in hormone-dependent and hormone-independent rat mammary carcinoma. Cancer Res. 1971 Oct;31(10):1440–1445. [PubMed] [Google Scholar]
  28. Miller W. R., McDonald D., Forrest A. P., Shivas A. A. Metabolism of androgens by human breast tissue. Lancet. 1973 Apr 28;1(7809):912–913. doi: 10.1016/s0140-6736(73)91363-9. [DOI] [PubMed] [Google Scholar]
  29. Nagasawa H., Meites J. Effects of a hypothalamic estrogen implant on growth of carcinogen-induced mammary tumors in rats. Cancer Res. 1970 May;30(5):1327–1329. [PubMed] [Google Scholar]
  30. PEARSON O. H., WEST C. D., HOLLANDER V. P., TREVES N. E. Evaluation of endocrine therapy for advanced breast cancer. J Am Med Assoc. 1954 Jan 16;154(3):234–239. doi: 10.1001/jama.1954.02940370046013. [DOI] [PubMed] [Google Scholar]
  31. Pearson O. H., Llerena O., Llerena L., Molina A., Butler T. Prolactin-dependent rat mammary cancer: a model for man? Trans Assoc Am Physicians. 1969;82:225–238. [PubMed] [Google Scholar]
  32. RAVEN R. W. Cancer of the breast treated by oophorectomy. Br Med J. 1950 Jun 10;1(4666):1343–1345. doi: 10.1136/bmj.1.4666.1343. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. SYDNOR K. L., COCKRELL B. INFLUENCE OF ESTRADIOL-17-BETA, PROGESTERONE AND HYDROCORTISONE ON 3-METHYLCHOLANTHRENE-INDUCED MAMMARY CANCER IN INTACT AND OVARIECTOMIZED SPRAGUE-DAWLEY RATS. Endocrinology. 1963 Oct;73:427–432. doi: 10.1210/endo-73-4-427. [DOI] [PubMed] [Google Scholar]
  34. Stewart H. J., Benson E. A., Roberts M. M., Forrest A. P., Greenwood F. C. Pituitary function after yttrium implants as measured by plasma growth hormone levels. J Endocrinol. 1971 May;50(1):41–50. doi: 10.1677/joe.0.0500041. [DOI] [PubMed] [Google Scholar]
  35. Turkington R. W., Underwood L. E., Van Wyk J. J. Elevated serum prolactin levels after pituitary-stalk section in man. N Engl J Med. 1971 Sep 23;285(13):707–710. doi: 10.1056/NEJM197109232851302. [DOI] [PubMed] [Google Scholar]
  36. Welsch C. W., Meites J. Effects of a norethynodrel-mestranol combination (enovid) on development and growth of carcinogen-induced mammary tumors in female rats. Cancer. 1969 Mar;23(3):601–607. doi: 10.1002/1097-0142(196903)23:3<601::aid-cncr2820230312>3.0.co;2-x. [DOI] [PubMed] [Google Scholar]
  37. Wilson R. G., Buchan R., Roberts M. M., Forrest A. P. Prolactin and breast cancer. Proc R Soc Med. 1973 Sep;66(9):865–866. doi: 10.1177/003591577306600917. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. YOUNG S., BAKER R. A., HELFENSTEIN J. E. THE EFFECTS OF ANDROGENS ON INDUCED MAMMARY TUMOURS IN RATS. Br J Cancer. 1965 Mar;19:155–159. doi: 10.1038/bjc.1965.18. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology. Supplement (Royal College of Pathologists). are provided here courtesy of BMJ Publishing Group

RESOURCES